ClinicalTrials.Veeva

Menu

PRICO: OPTI Target Range (POSTR)

C

Czech Technical University in Prague

Status

Enrolling

Conditions

Very Low Birth Weight Infant
Neonatal Respiratory Distress

Treatments

Device: Narrow TR
Device: Shifted TR

Study type

Interventional

Funder types

Other

Identifiers

NCT06207994
PricoOptiTR

Details and patient eligibility

About

The aim of the study is to determine if a narrower SpO2 Target Range setting automated control of FiO2 (A-FiO2) is more effective than a wider SpO2 Target Range

Full description

A-FiO2 systems have consistently proven to be more effective than manual control. Because it is more precise than manual control, studies of some A-FiO2 systems found small differences in the set target range (shift in the median and width) can optimize the relative performance. Similar studies of the A-FiO2 system (PRICO) used in the investigator's NICU have not been conducted.

The standard of practice in the investigator's NICU is to use 4 different target ranges to balance the risk of hypoxia and hyperoxia based on the gestational age vulnerabilities. Based on the studies of other A-FiO2 systems the investigators believe a slightly narrower width target range would be more effective. Therefore, a small systematic study is needed to determine the optimal set target range to achieve the therapeutic goal.

Enrollment

10 estimated patients

Sex

All

Ages

2+ weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All VLBW on respiratory support and oxygen requirements after 2 weeks of age in the NICU are eligible after informed consent is obtained.

Exclusion criteria

  • Informed consent is not obtained
  • Recording device for automated control of FiO2 is not available

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

10 participants in 3 patient groups

Standard Target Range
No Intervention group
Description:
The SpO2 TR width is set to 5% SpO2, as is routine in the department. The actual TR will vary depending on the GA, as is standard practice in the department.
Narrow Target Range
Experimental group
Description:
The SpO2 TR width is set narrower than the Standard TR. The actual TR will vary depending on the GA, as is standard practice in the department.
Treatment:
Device: Narrow TR
Shifted Target Range
Experimental group
Description:
The SpO2 TR width is set as the Standard TR. The median of the TR is shifted up compared to the Standard TR. The actual TR will vary depending on the GA, as is standard practice in the department.
Treatment:
Device: Shifted TR

Trial contacts and locations

1

Loading...

Central trial contact

Jakub Rafl, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems